Radovich Peter 4

What Happened

• Peter Radovich, President and COO of Mirum Pharmaceuticals (MIRM), disposed of 2,631 shares on 2026-02-02 at $103.30 per share, totaling $271,792. The sale is reported as a sell-to-cover related to restricted stock units (RSUs), meaning shares were sold to satisfy tax withholding obligations rather than as a standalone open-market investment decision.

Key Details

• Transaction date and price: 2026-02-02 at $103.30 per share (total proceeds $271,792).
• Transaction type: Sale (reported as "open market or private sale"); coded S with footnote F1 indicating tax withholding.
• Reason given (footnote): Shares sold to cover tax withholding obligations associated with RSU vesting (sell-to-cover).
• Shares owned after transaction: Not disclosed in this filing.
• Filing timeliness: Reported on 2026-02-03 for a 2026-02-02 transaction (filed promptly; no late-filing flag).

Context

• Sell-to-cover transactions are common when RSUs vest and do not necessarily reflect the insider's opinion about the company's prospects. This is a routine tax-related disposition rather than a market-timing purchase.